Male Breast Carcinoma — Trials

Male Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

104 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01219907	Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer	withdrawn	Phase 1	0	University of WashingtonOTHER	1	May 17, 2013	clinicaltrials

Data updated 23 days agoSource updated May 17, 2013source: clinicaltrials